Healthcare Mid-Caps Poised for Earnings Recovery Amid Sector Lag

The healthcare sector is entering the Q1 2026 earnings cycle as one of the market's primary laggards, creating a potential opportunity for investors focusing on mid-cap companies with strong fundamental revisions. Performance data shows that the Health Care Select Sector SPDR Fund (XLV) recorded a 5.29% decline during the first quarter of 2026. This performance slightly trailed the broader S&P 500, which fell 4.63% in the same period, as both indices grappled with persistent inflationary pressures. Despite the overall sector weakness, a specific subset of mid-cap healthcare stocks has maintained 'A grade' earnings per share (EPS) revisions. These upward adjustments suggest that analysts expect these specific companies to outperform their previous earnings estimates despite the challenging macro environment. Market participants are now shifting focus toward these high-revision mid-caps as a strategy to find alpha within a struggling sector. The divergence between the broad XLV performance and specific mid-cap revisions may signal a potential rotation or a recovery phase for select healthcare players as reporting begins.